Search

William Hernandez

Examiner (ID: 1948, Phone: (571)272-8979 , Office: P/2842 )

Most Active Art Unit
2842
Art Unit(s)
2836, 2842, 2849, 2816
Total Applications
1509
Issued Applications
1397
Pending Applications
53
Abandoned Applications
84

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4745293 [patent_doc_number] => 20080089895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Use of T-cell immune response cDNA 7 (TIRC7) in angiogenic and anti-angiogenic therapy' [patent_app_type] => utility [patent_app_number] => 11/906867 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9545 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089895.pdf [firstpage_image] =>[orig_patent_app_number] => 11906867 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/906867
Use of T-cell immune response cDNA 7 (TIRC7) in angiogenic and anti-angiogenic therapy Oct 3, 2007 Abandoned
Array ( [id] => 23893 [patent_doc_number] => 07795234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Newly identified human small intestine extracellular lactase-phlorizin hydrolase (ecLPH) gene' [patent_app_type] => utility [patent_app_number] => 11/901989 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 20 [patent_no_of_words] => 6372 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795234.pdf [firstpage_image] =>[orig_patent_app_number] => 11901989 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/901989
Newly identified human small intestine extracellular lactase-phlorizin hydrolase (ecLPH) gene Sep 19, 2007 Issued
Array ( [id] => 4785485 [patent_doc_number] => 20080138814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Compositions and Methods for Modulation of KSR1 and KSR2 Interactions' [patent_app_type] => utility [patent_app_number] => 11/833029 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 11318 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138814.pdf [firstpage_image] =>[orig_patent_app_number] => 11833029 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/833029
Compositions and methods for modulation of KSR1 and KSR2 interactions Aug 1, 2007 Issued
Array ( [id] => 4740563 [patent_doc_number] => 20080234216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'TGF-beta type receptor cDNAs encoded products and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/880894 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9711 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234216.pdf [firstpage_image] =>[orig_patent_app_number] => 11880894 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/880894
TGF-beta type receptor cDNAs encoded products and uses therefor Jul 23, 2007 Abandoned
Array ( [id] => 4727999 [patent_doc_number] => 20080207543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'MODIFIED PITUITARY GLAND DEVELOPMENT IN OFFSPRING FROM EXPECTANT MOTHER ANIMALS TREATED WITH GROWTH HORMONE RELEASING HORMONE THERAPY' [patent_app_type] => utility [patent_app_number] => 11/774954 [patent_app_country] => US [patent_app_date] => 2007-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18874 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207543.pdf [firstpage_image] =>[orig_patent_app_number] => 11774954 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/774954
MODIFIED PITUITARY GLAND DEVELOPMENT IN OFFSPRING FROM EXPECTANT MOTHER ANIMALS TREATED WITH GROWTH HORMONE RELEASING HORMONE THERAPY Jul 8, 2007 Abandoned
Array ( [id] => 4664095 [patent_doc_number] => 20080255002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Genetic manipulation method' [patent_app_type] => utility [patent_app_number] => 11/809578 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22003 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255002.pdf [firstpage_image] =>[orig_patent_app_number] => 11809578 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/809578
Genetic manipulation method May 30, 2007 Abandoned
Array ( [id] => 5027965 [patent_doc_number] => 20070269412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'PLURIPOTENT CELLS' [patent_app_type] => utility [patent_app_number] => 11/755224 [patent_app_country] => US [patent_app_date] => 2007-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10394 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269412.pdf [firstpage_image] =>[orig_patent_app_number] => 11755224 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/755224
PLURIPOTENT CELLS May 29, 2007 Abandoned
Array ( [id] => 4976846 [patent_doc_number] => 20070218077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response' [patent_app_type] => utility [patent_app_number] => 11/749509 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23072 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218077.pdf [firstpage_image] =>[orig_patent_app_number] => 11749509 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/749509
Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response May 15, 2007 Abandoned
Array ( [id] => 4839436 [patent_doc_number] => 20080279921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Gel-formulations of hydrophobic photosensitizers for mucosal applications' [patent_app_type] => utility [patent_app_number] => 11/800599 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2366 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279921.pdf [firstpage_image] =>[orig_patent_app_number] => 11800599 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/800599
Gel-formulations of hydrophobic photosensitizers for mucosal applications May 6, 2007 Abandoned
Array ( [id] => 4959744 [patent_doc_number] => 20080274169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Photosensitizer formulations for topical applications' [patent_app_type] => utility [patent_app_number] => 11/800147 [patent_app_country] => US [patent_app_date] => 2007-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3171 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274169.pdf [firstpage_image] =>[orig_patent_app_number] => 11800147 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/800147
Photosensitizer formulations for topical applications May 3, 2007 Abandoned
Array ( [id] => 5091665 [patent_doc_number] => 20070231304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'PROGNOSTIC FACTORS FOR ANTI-HYPERPROLIFERATIVE DISEASE GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 11/668981 [patent_app_country] => US [patent_app_date] => 2007-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 44909 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231304.pdf [firstpage_image] =>[orig_patent_app_number] => 11668981 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/668981
PROGNOSTIC FACTORS FOR ANTI-HYPERPROLIFERATIVE DISEASE GENE THERAPY Jan 29, 2007 Abandoned
Array ( [id] => 5259642 [patent_doc_number] => 20070213274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Novel genes and markers associated with high-density lipoprotein-cholesterol (HDL-C)' [patent_app_type] => utility [patent_app_number] => 11/640897 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84858 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213274.pdf [firstpage_image] =>[orig_patent_app_number] => 11640897 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/640897
Novel genes and markers associated with high-density lipoprotein-cholesterol (HDL-C) Dec 18, 2006 Abandoned
Array ( [id] => 5070195 [patent_doc_number] => 20070191297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'METHODS OF TREATING AND MONITORING SYSTEMIC LUPUS ERYTHEMATOSUS IN INDIVIDUALS' [patent_app_type] => utility [patent_app_number] => 11/565467 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 26066 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191297.pdf [firstpage_image] =>[orig_patent_app_number] => 11565467 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/565467
METHODS OF TREATING AND MONITORING SYSTEMIC LUPUS ERYTHEMATOSUS IN INDIVIDUALS Nov 29, 2006 Abandoned
Array ( [id] => 5095073 [patent_doc_number] => 20070116682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/604909 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16798 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20070116682.pdf [firstpage_image] =>[orig_patent_app_number] => 11604909 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/604909
Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof Nov 27, 2006 Abandoned
Array ( [id] => 5095075 [patent_doc_number] => 20070116684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/604918 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16792 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20070116684.pdf [firstpage_image] =>[orig_patent_app_number] => 11604918 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/604918
Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof Nov 27, 2006 Abandoned
Array ( [id] => 4825815 [patent_doc_number] => 20080124802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Method for labeling specific cells within living cells or tissues' [patent_app_type] => utility [patent_app_number] => 11/598690 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5313 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124802.pdf [firstpage_image] =>[orig_patent_app_number] => 11598690 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/598690
Method for labeling specific cells within living cells or tissues Nov 13, 2006 Abandoned
Array ( [id] => 4895622 [patent_doc_number] => 20080104722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'DISEASE MODEL ANIMALS OF METABOLIC SYNDROME AND A METHOD OF SCREENING PREVENTIVE AND THERAPEUTIC AGENTS FOR METABOLIC SYNDROME USING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/553125 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7867 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20080104722.pdf [firstpage_image] =>[orig_patent_app_number] => 11553125 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/553125
DISEASE MODEL ANIMALS OF METABOLIC SYNDROME AND A METHOD OF SCREENING PREVENTIVE AND THERAPEUTIC AGENTS FOR METABOLIC SYNDROME USING THE SAME Oct 25, 2006 Abandoned
Array ( [id] => 5125840 [patent_doc_number] => 20070238111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability' [patent_app_type] => utility [patent_app_number] => 11/584580 [patent_app_country] => US [patent_app_date] => 2006-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 8781 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238111.pdf [firstpage_image] =>[orig_patent_app_number] => 11584580 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/584580
Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability Oct 22, 2006 Issued
Array ( [id] => 5080772 [patent_doc_number] => 20070123996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Stem cell comprising tissue substitutes' [patent_app_type] => utility [patent_app_number] => 11/582057 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23466 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123996.pdf [firstpage_image] =>[orig_patent_app_number] => 11582057 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/582057
Tissue substitutes comprising stem cells and reduced ceria Oct 15, 2006 Issued
Array ( [id] => 4982425 [patent_doc_number] => 20070086983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Endothelium-targeting nanoparticle for reversing endothelial dysfunction' [patent_app_type] => utility [patent_app_number] => 11/545370 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12652 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20070086983.pdf [firstpage_image] =>[orig_patent_app_number] => 11545370 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/545370
Endothelium-targeting nanoparticle for reversing endothelial dysfunction Oct 9, 2006 Abandoned
Menu